Further, the percentage of infiltrating CD8+ T cells in tumours 24 h after treatment was 32.35% or 19.43% of the total number of lymphocytes for 0.8 MPa or 2.4 MPa, respectively. This evidence concerns the gene CD8A and neoplasm.